Nickerson Joan
Insider CIK 1964461 · VERV Chief Administrative Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 6,630 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 125,000 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 102,016 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 18,000 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 40,000 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 225,000 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | U Tender | 2025-07-25 | 2025-07-28 | 17,420 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2025-04-02 | 2025-04-03 | 2,777 | $4.15 | $11.5K | 17,420 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise deriv | 2025-04-01 | 2025-04-03 | 6,000 | — | $0 | 18,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise deriv | 2025-04-01 | 2025-04-03 | 3,315 | — | $0 | 6,630 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise | 2025-04-01 | 2025-04-03 | 9,315 | — | $0 | 20,197 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2025-01-08 | 2025-01-10 | 225,000 | — | $0 | 225,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2025-01-08 | 2025-01-10 | 40,000 | — | $0 | 40,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2024-04-02 | 2024-04-03 | 1,514 | $8.24 | $12.5K | 8,659 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise deriv | 2024-04-01 | 2024-04-03 | 3,315 | — | $0 | 9,945 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise | 2024-04-01 | 2024-04-03 | 3,315 | — | $0 | 10,173 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2024-02-14 | 2024-02-16 | 125,000 | — | $0 | 125,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2024-02-14 | 2024-02-16 | 24,000 | — | $0 | 24,000 | SEC↗ |